Solanet Juan J, Malena Rosana, Estein Silvia M, Estevao Belchior Silvia, Paolicchi Fernando A
Residencia Interna en Salud Animal, Departamento de Producción Animal, Instituto Nacional de Tecnología Agropecuaria (INTA).
Rev Argent Microbiol. 2011 Jan-Mar;43(1):9-17. doi: 10.1590/S0325-75412011000100003.
The aim of this study was to evaluate an indirect specific ELISA developed for the detection of humoral immune response in vaccinated sheep and/or challenged with a Corynebacterium pseudotuberculosis strain. Healthy 4 month-old lambs were distributed into 4 groups: Group 1 immunized (G1, n = 5), Group 2 vaccinated/inoculated (G2, n = 8), Group 3 inoculated (G3, n = 2) and Group 4 control (G4, n = 2). Groups G1 and G2 received two doses of an experimental bacterin. Four weeks postvaccination, G2 and G3 groups were challenged with a C. pseudotuberculosis strain. Serological titers were studied by ELISA for 7 months and pathological studies were performed in groups G2, G3 and G4 by taking lung and lymph node samples for bacteriology and histopathology. The inoculated strain in G2 and G3 animals reproduced the macroscopic and microscopic lesions typical of caseous lymphadenitis (CL) and was isolated from the inoculation site, lymph nodes and/or lung in 7/8 animals from G2, and 2/2 animals of G3. The developed ELISA test had sensitivity and specificity of 98% and 100% respectively, detected significant differences between serological reactors of different experimental groups and allowed to establish a relationship with the type of treatment. We conclude that the developed ELISA may be a useful tool to identify infected animals with positive clinical CL.
本研究的目的是评估一种间接特异性酶联免疫吸附测定法(ELISA),该方法用于检测接种疫苗的绵羊和/或用假结核棒状杆菌菌株攻击后的体液免疫反应。将健康的4月龄羔羊分为4组:第1组为免疫组(G1,n = 5),第2组为接种/接种组(G2,n = 8),第3组为接种组(G3,n = 2),第4组为对照组(G4,n = 2)。G1组和G2组接受两剂实验性菌苗。接种疫苗4周后,G2组和G3组用假结核棒状杆菌菌株攻击。通过ELISA研究血清学滴度7个月,并对G2、G3和G4组进行病理学研究,采集肺和淋巴结样本进行细菌学和组织病理学检查。G2组和G3组动物接种的菌株再现了干酪性淋巴结炎(CL)典型的宏观和微观病变,并且从接种部位、淋巴结和/或肺中分离出该菌株,G2组8只动物中有7只,G3组2只动物中有2只。所开发的ELISA试验的敏感性和特异性分别为98%和100%,检测到不同实验组血清学反应者之间存在显著差异,并能够建立与治疗类型的关系。我们得出结论,所开发的ELISA可能是识别临床CL阳性感染动物的有用工具。